Advertisement
Screener

PharMerica CORP Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed

PharMerica CORP Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed

PharMerica CORP reported Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed of $3.60 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-02.

Discontinued › Expense Statement › Operating Expenses

us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed · last filed 2017-08-02

  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2017-06-30 was $3.60M, a 18.18% decline year-over-year.
  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2017-03-31 was $3.60M, a 16.28% decline year-over-year.
  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2016-09-30 was $5.20M, a 31.58% decline year-over-year.
  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for the quarter ending 2016-06-30 was $4.40M, a 33.33% increase year-over-year.
  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2013 was $5.90M, a 44.86% decline from fiscal 2012.
  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2012 was $10.70M, a 17.05% decline from fiscal 2011.
  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2011 was $12.90M, a 148.08% increase from fiscal 2010.
  • PharMerica CORP business combination, separately recognized transactions, additional disclosures, acquisition cost expensed for fiscal 2010 was $5.20M.
Period endBusiness Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 3 monthBusiness Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 6 monthBusiness Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 9 monthBusiness Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed 12 month
2017-06-30$3.60M
10-Q · filed 2017-08-02
$7.10M
10-Q · filed 2017-08-02
2017-03-31$3.60M
10-Q · filed 2017-05-10
2016-09-30$5.20M
10-Q · filed 2016-11-09
$9.60M
derived: sum of 2 quarters · filed 2017-08-02
$13.90M
10-Q · filed 2016-11-09
2016-06-30$4.40M
10-Q · filed 2017-08-02
$8.70M
10-Q · filed 2017-08-02
2016-03-31$4.30M
10-Q · filed 2017-05-10
2015-09-30$7.60M
10-Q · filed 2016-11-09
$10.90M
derived: sum of 2 quarters · filed 2016-11-09
$14.70M
10-Q · filed 2016-11-09
2015-06-30$3.30M
10-Q · filed 2016-08-09
$7.00M
10-Q · filed 2016-08-09
2015-03-31$3.70M
10-Q · filed 2016-05-06
2014-09-30$3.70M
10-Q · filed 2015-11-06
$5.10M
derived: sum of 2 quarters · filed 2015-11-06
$10.00M
10-Q · filed 2015-11-06
$13.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$1.40M
10-Q · filed 2015-08-07
$6.30M
10-Q · filed 2015-08-07
$9.30M
derived: sum of 3 quarters · filed 2016-02-26
$10.30M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$4.90M
10-Q · filed 2015-05-07
$7.90M
derived: sum of 2 quarters · filed 2016-02-26
$8.90M
derived: sum of 3 quarters · filed 2016-02-26
$9.50M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$4.00M
derived: sum of 2 quarters · filed 2016-02-26
$4.60M
derived: sum of 3 quarters · filed 2016-02-26
$5.90M
10-K · filed 2016-02-26
2013-09-30$1.00M
10-Q · filed 2013-11-05
$1.60M
derived: sum of 2 quarters · filed 2013-11-05
$2.90M
10-Q · filed 2013-11-05
$5.00M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$600.00K
10-Q · filed 2013-08-02
$2.00M
10-Q · filed 2013-08-02
$4.00M
derived: sum of 3 quarters · filed 2015-03-02
$7.90M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$1.40M
10-Q · filed 2013-05-01
$3.40M
derived: sum of 2 quarters · filed 2015-03-02
$7.30M
derived: sum of 3 quarters · filed 2015-03-02
$9.60M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$5.90M
derived: sum of 2 quarters · filed 2015-03-02
$8.20M
derived: sum of 3 quarters · filed 2015-03-02
$10.70M
10-K · filed 2015-03-02
2012-09-30$3.90M
10-Q · filed 2012-11-01
$6.20M
derived: sum of 2 quarters · filed 2013-11-05
$8.70M
10-Q · filed 2013-11-05
$10.40M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30$2.30M
10-Q · filed 2013-08-02
$4.80M
10-Q · filed 2013-08-02
$6.50M
derived: sum of 3 quarters · filed 2014-02-28
$8.60M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31$2.50M
10-Q · filed 2013-05-01
$4.20M
derived: sum of 2 quarters · filed 2014-02-28
$6.30M
derived: sum of 3 quarters · filed 2014-02-28
$10.80M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$3.80M
derived: sum of 2 quarters · filed 2014-02-28
$8.30M
derived: sum of 3 quarters · filed 2014-02-28
$12.90M
10-K · filed 2014-02-28
2011-09-30$2.10M
10-Q · filed 2012-11-01
$6.60M
derived: sum of 2 quarters · filed 2012-11-01
$11.20M
10-Q · filed 2012-11-01
2011-06-30$4.50M
10-Q · filed 2012-08-02
$9.10M
10-Q · filed 2012-08-02
2010-12-31$5.20M
10-K · filed 2013-02-07